Gurney; Mark

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gurney; Mark.The latest application filed is for "heteroaryl inhibitors of pde4".

Company Profile

0.8.16

Gurney; Mark - Grand Rapids MI
Gurney; Mark - East Grand Rapids MI
Gurney; Mark - E. Grand Rapids MI
Gurney; Mark - Woodridge IL
Gurney, Mark - Reykjavik IS

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Heteroaryl Inhibitors Of Pde4 App 20150086480 - D'Amato; Emily Catherine ; et al.	2015-03-26
Biaryl substituted heterocycle inhibitors of LTA4H for treating inflammation Grant 8,598,359 - Sandanayaka , et al. December 3, 2	2013-12-03
Cyclic carboxylic acid rhodanine derivatives for the treatment and prevention of tuberculosis Grant 8,338,465 - Singh , et al. December 25, 2	2012-12-25
Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment Grant 7,851,486 - Helgadottir , et al. December 14, 2	2010-12-14
Cyclic Carboxylic Acid Rhodanine Derivatives For The Treatment And Prevention Of Tuberculosis App 20100210577 - Singh; Jasbir ; et al.	2010-08-19
Carboxylic acid peri-substituted bicyclics for occlusive artery disease Grant 7,714,017 - Singh , et al. May 11, 2	2010-05-11
Alzheimer's Disease Secretase, APP Substrates Thereof, and Uses Thereof App 20090162883 - Gurney; Mark ; et al.	2009-06-25
Biaryl Substituted Heterocycle Inhibitors Of Lta4h For Treating Inflammation App 20090163462 - SANDANAYAKA; Vincent ; et al.	2009-06-25
Aryl Sulfonamide Peri-substituted Bicyclics For Occlusive Artery Disease App 20090075985 - Singh; Jasbir ; et al.	2009-03-19
Neuregulin-1 transgenic mouse and methods of use Grant 7,495,147 - Stefansson , et al. February 24, 2	2009-02-24
Neuregulin-1 Transgenic Mouse And Methods Of Use App 20080263690 - Stefansson; Hreinn ; et al.	2008-10-23
Biaryl substituted heterocycle inhibitors of LTA4H for treating inflammation Grant 7,402,684 - Sandanayaka , et al. July 22, 2	2008-07-22
7-(acryloyl) Indole Compositions And Methods Of Making And Using Same App 20080125477 - Singh; Jasbir ; et al.	2008-05-29
Biaryl Substituted Heterocycle Inhibitors Of Lta4h For Treating Inflammation App 20070078263 - Sandanayaka; Vincent ; et al.	2007-04-05
Biaryl Substituted Heterocycle Inhibitors Of Lta4h For Treating Inflammation App 20070066820 - Sandanayaka; Vincent ; et al.	2007-03-22
Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease App 20060142348 - Singh; Jasbir ; et al.	2006-06-29
Carboxylic acid peri-substituted bicyclics for occlusive artery disease App 20060142355 - Singh; Jasbir ; et al.	2006-06-29
Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment App 20050282855 - Helgadottir, Anna ; et al.	2005-12-22
Methods of preventing or treating recurrence of myocardial infarction App 20050272051 - Helgadottir, Anna ; et al.	2005-12-08
Alzheimer's disease secretase, APP substrates thereof, and uses thereof App 20050196398 - Gurney, Mark ; et al.	2005-09-08
Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment App 20050113408 - Helgadottir, Anna ; et al.	2005-05-26
Alzheimer's disease secretase, APP substrates therefor, and uses therefor Grant 6,844,148 - Gurney , et al. January 18, 2	2005-01-18
Human schizophrenia gene App 20020165144 - Stefansson, Hreinn ; et al.	2002-11-07

Company Registrations

SEC

0001258051

GURNEY MARK

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.